Mutations in BMP9 and its' receptors underlie vascular diseases, namely hereditary hemorrhagic telangiectasia (ALK1, endoglin, and BMP9) (29, –31) and pulmonary arterial hypertension (ALK1, BMPR2) (32, –34). This evidence concerns the gene GDF2 and hereditary hemorrhagic telangiectasia.